ExpreS2ion Biotech Holding AB (ExpreS2ion) announced that the Company's Board of Directors has appointed Bent U. Frandsen as the new Chief Executive Officer of ExpreS2ion, succeeding Steen Klysner as of 20 December, 2019. Bent has been with the company since March 2016 and has served as the Company's Chief Business Officer since August 2018.